2019
DOI: 10.1021/acs.jmedchem.8b01985
|View full text |Cite
|
Sign up to set email alerts
|

Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands

Abstract: Interest is growing in the use of macrocycles in pharmaceutical discovery. Macrocylization may provide a gateway to an expanded chemical space for small-molecule drug discovery, and this could be beneficial in prosecuting difficult targets, e.g., protein–protein interactions. Most, but not all, macrocycle drugs are derived from natural products. Studies on synthetic drug-like small-molecule macrocycles are limited, and our current understanding of macrocycle drugs is similarly limited. Following some backgroun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
59
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 81 publications
(61 citation statements)
references
References 90 publications
(151 reference statements)
2
59
0
Order By: Relevance
“…16,20,21 Bisucaberin has been shown to have anti-cancer potential through Fe(III) deprivation mechanisms, 17 which provides impetus to exploring methods beyond total synthesis to improve access to these types of molecules and to allow increased structural diversity. This is in accord with the broader potential of macrocycles as useful drug leads and inhibitors of protein-protein interactions, [23][24][25][26][27][28] which underpins developments in macrocycle synthesis.…”
Section: Introductionmentioning
confidence: 68%
“…16,20,21 Bisucaberin has been shown to have anti-cancer potential through Fe(III) deprivation mechanisms, 17 which provides impetus to exploring methods beyond total synthesis to improve access to these types of molecules and to allow increased structural diversity. This is in accord with the broader potential of macrocycles as useful drug leads and inhibitors of protein-protein interactions, [23][24][25][26][27][28] which underpins developments in macrocycle synthesis.…”
Section: Introductionmentioning
confidence: 68%
“…The CSD-Crossminer is the novel software of the Cambridge Crystallographic Data Centre first appeared as part of the CSD-Enterprise in 2018. Its utility is based on ideas previously demonstrated on the example of carboxylate/tetrazolate [115], hydrate/peroxosovate [116], and maleate/saccharinate [82] behavior in solids and potential of 3D macrocyclic analogues of small-molecules to serve as drugs [117]. Particularly, molecules which form similar intermolecular interactions and have comparable size and shape tend to form similar supramolecular associates, and hence are able to form isotypical solvates, or bind with similar functional groups within a binding pocket of a macromolecule.…”
Section: Csd-crossminermentioning
confidence: 99%
“…In pharmaceutical discovery, a macrocycle is defined as a ring system of 12 or more atoms, and it has shown great potential in drug development due to its attractive features . Compared to acyclic structures, macrocycles limit the rotation of internal bonds, resulting in the ability to remain in an active conformation with a degree of conformational stability .…”
Section: Background and Originality Contentmentioning
confidence: 99%